ZION
65
2
SYY
53
4
AAP
24
6
DRI
53
5
EL
25
4
TGT
22
2
NSC
60
3
NWS
66
-3
MLM
57
6
KMB
39
2
ADT
53
3
KMI
67
-2
CPB
30
6
JWN
48
6
HON
67
2
WFC
79
4
CSX
60
3
XRAY
28
2
WY
54
4
EFX
38
2
ZION
65
2
SYY
53
4
AAP
24
6
DRI
53
5
EL
25
4
TGT
22
2
NSC
60
3
NWS
66
-3
MLM
57
6
KMB
39
2
ADT
53
3
KMI
67
-2
CPB
30
6
JWN
48
6
HON
67
2
WFC
79
4
CSX
60
3
XRAY
28
2
WY
54
4
EFX
38
2
Financhill
Back

Dermata Therapeutics Vs. ZyVersa Therapeutics Industry Stock Comparison

Sell
20

DRMA
Dermata Therapeutics

Last Price:
1.11
Seasonality Move:
-52.03%
Sell
8

ZVSA
ZyVersa Therapeutics

Last Price:
1.12
Seasonality Move:
-78.1%
Sell
20
Dermata Therapeutics (DRMA) is a Sell

Is Dermata Therapeutics a Buy, Sell or Hold?

  • The current Dermata Therapeutics [DRMA] share price is $1.14. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
8
ZyVersa Therapeutics (ZVSA) is a Sell

Is ZyVersa Therapeutics a Buy, Sell or Hold?

  • The current ZyVersa Therapeutics [ZVSA] share price is $1.13. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • ZVSA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DRMA Stock Price Chart

What is Dermata Therapeutics's stock price today?

  • The Dermata Therapeutics share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZVSA Stock Price Chart

What is ZyVersa Therapeutics's stock price today?

  • The ZyVersa Therapeutics share price today is $1.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 21797 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.16 - 1.44) Sell
Bollinger Bands (100): (1.28 - 2.18) Sell

ZVSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 32.04 Sell
Chaikin Money Flow: 123461 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 2.11) Sell
Bollinger Bands (100): (1.74 - 3.62) Sell

DRMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.14 Sell
20-day SMA: 1.25 Sell
50-day SMA: 1.44 Sell
200-day SMA: 3.36 Sell
8-day EMA: 1.16 Sell
20-day EMA: 1.24 Sell
50-day EMA: 1.44 Sell
200-day EMA: 6.18 Sell

ZVSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.17 Sell
20-day SMA: 1.54 Sell
50-day SMA: 1.98 Sell
200-day SMA: 4.44 Sell
8-day EMA: 1.22 Sell
20-day EMA: 1.48 Sell
50-day EMA: 1.96 Sell
200-day EMA: 41.76 Sell

Dermata Therapeutics Earnings Growth & DRMA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ZyVersa Therapeutics Earnings Growth & ZVSA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $698.82 per share, and an increase next year of $11.20 per share.

Dermata Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ZyVersa Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):